Catalyst Wire Dossier Catalyst Wire Dossier

PepCan

· University of Arkansas
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PepCan, covering 2023-12-18 to 2025-10-08. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I/II Clinical Trial of PepCan in Head and Neck Cancer Patients [Phase 1, Phase 2]

See pricing